Skip to main content
Log in

Author’s reply to Veloso HH Comment on “The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm”

  • Letter to the Editor
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Veloso HH. Comment on: “The role of digitalis pharmacokinetics in converting atrial fibrillation and flutter to sinus rhythm”. Clin Pharmacokinet. 2016. doi:10.1007/s40262-016-0380-9.

  2. Jelliffe R. The role of digitalis pharmacokinetics in converting atrial fibrillation and flutter to sinus rhythm. Clin Pharmacokinet. 2014;53:397–407.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Falk R, Knowlton A, Bernard S, Gotlieb N, Battinelli N. Digoxin for converting atrial fibrillation to sinus rhythm: a random double-blinded trial. Ann Int Med. 1987;4:503–6.

    Article  Google Scholar 

  4. Bianconi L, Mennuni M, For the PATIF-3 Investigators. Comparison between propafenone and digoxin administered intravenously to patients with atrial fibrillation. Am J Cardiol. 1998;82:584–8.

  5. Reuning R, Sams R, Notari R. Role of pharmacokinetics in drug dosage adjustment. 1. Pharmacologic effects, kinetics, and apparent volume of distribution of digoxin. J Clin Pharmacol. 1973;13:127–41.

    CAS  Google Scholar 

  6. Jelliffe R, Milman M, Schumitzky A, Bayard D, Van Guilder M. A two-compartment population pharmacokinetic–pharmacodynamic model of digoxin in adults, with implications for dosage. Ther Drug Monit. 2014;36(3):387–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. The USC Pmetrics and RightDose software. The only software with integrated pop modeling, simulation, and maximally precise dosage: Jelliffe R, Schumitzky A, Bayard D, Van Guilder M, Botnen A, Neely M, Thomson A, Bustad A. Laboratory of Applied Pharmacokinetics, USC Keck School of Medicine, Los Angeles (CA). A software demonstration at the Population Approach Group Europe, 11–14 June 2013, Glasgow, Scotland.

  8. D’Argenio D. Optimal sampling times for pharmacokinetic experiments. J Pharmacokinet Biopharmacol. 1981;9:739–56.

    Article  Google Scholar 

  9. Bayard D, Jelliffe R. A Bayesian approach to tracking patients having changing pharmacokinetic parameters. J Pharmacokinet Pharmacodyn. 2004;31(1):75–107.

    Article  PubMed  Google Scholar 

  10. Macdonald I, Staatz C, Jelliffe R, Thomson A. Evaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of gentamicin and vancomycin data collected from patients undergoing cardiothoracic surgery. Ther Drug Monit. 2008;30:67–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Blom H. An efficient filter for abruptly changing systems. In: Proceedings of the 23rd conference on decision and control; Las Vegas (NV); 1984, pp. 656–8.

  12. Blom H, Bar-Shalom Y. The interacting multiple model algorithm for systems with Markovian switching coefficients. IEEE Trans Autom Control. 1988;33:780–3.

    Article  Google Scholar 

  13. Mazor E, Averbuch A, Bar-Shalom Y, Dayan J. Interacting multiple model methods in target tracking: a survey. IEEE Trans Aerosp Electron Syst. 1998;34:103–23.

    Article  Google Scholar 

  14. Doherty J. Digitalis glycosides: pharmacokinetics and their clinical implications. Ann Int Med. 1973;79:229–38.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roger W. Jelliffe.

Ethics declarations

Funding

No external sources of funding were used in the preparation of this manuscript.

Conflicts of interest

Roger W. Jelliffe has no conflicts of interest that might be relevant to the contents of this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jelliffe, R.W. Author’s reply to Veloso HH Comment on “The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm”. Clin Pharmacokinet 55, 637–639 (2016). https://doi.org/10.1007/s40262-016-0381-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-016-0381-8

Keywords

Navigation